LYZERTRI Trademark

Trademark Overview

On Wednesday, November 18, 2020, a trademark application was filed for LYZERTRI with the United States Patent and Trademark Office. The USPTO has given the LYZERTRI trademark a serial number of 90327993. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2024. This trademark is owned by JOHNSON & JOHNSON. The LYZERTRI trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
lyzertri

General Information

Serial Number90327993
Word MarkLYZERTRI
Filing DateWednesday, November 18, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 1, 2021

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Saturday, November 21, 2020NEW APPLICATION ENTERED
Monday, January 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 21, 2021ASSIGNED TO EXAMINER
Friday, April 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 12, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 1, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 1, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 5, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, January 5, 2022SOU EXTENSION 1 FILED
Wednesday, January 5, 2022SOU EXTENSION 1 GRANTED
Friday, January 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 27, 2022SOU TEAS EXTENSION RECEIVED
Monday, June 27, 2022SOU EXTENSION 2 FILED
Monday, June 27, 2022SOU EXTENSION 2 GRANTED
Wednesday, June 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 19, 2022SOU TEAS EXTENSION RECEIVED
Monday, December 19, 2022SOU EXTENSION 3 FILED
Monday, December 19, 2022SOU EXTENSION 3 GRANTED
Wednesday, December 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 6, 2023SOU EXTENSION 4 FILED
Thursday, July 6, 2023SOU EXTENSION 4 GRANTED
Saturday, July 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 4, 2023ASSIGNED TO EXAMINER
Tuesday, January 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 16, 2024SOU EXTENSION 5 FILED
Friday, February 2, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 2, 2024SOU EXTENSION 5 GRANTED
Saturday, February 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

lyzertri diseases anti system metabolic oncologic ophthalmic related intestinal infectious respiratory